Biomics Biopharma (ASX:BBM) Other Income (Expense) : A$ Mil (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Other Income (Expense)?

Biomics Biopharma's other income expense for the Biomics Biopharma's pretax income for the six months ended in . 20 was A$0.00 Mil.

Biomics Biopharma Other Income (Expense) Historical Data

The historical data trend for Biomics Biopharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Other Income (Expense) Chart

Biomics Biopharma Annual Data

Trend

Other Income (Expense)

Biomics Biopharma Semi-Annual Data

Other Income (Expense)

Biomics Biopharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Biomics Biopharma (ASX:BBM) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Other Income (Expense)

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines